Introduction
============

The reciprocal interactions between neurons and glial cells are essential for the coordinated differentiation of axons and myelin-forming cells, which allow myelinating fibers to maximize their conduction velocity ([@bib1]; [@bib29]). The closest contact site between the axon and its myelinating Schwann cells or oligodendrocytes is found at the paranodal region that flanks the node of Ranvier. At this site, the cytoplasmic loops of the myelinating cell create a septate-like junction with the axon, which separates the electrical activity at the nodes of Ranvier from the internodal region that lies under the compact myelin sheath ([@bib45]; [@bib37]). Three cell adhesion molecules have been identified thus far at the paranodes of both the peripheral nervous system (PNS)[\*](#fn1){ref-type="fn"} and central nervous system (CNS). These include an axonal complex that consists of Caspr (contactin-associated protein, also known as Paranodin) and the GPI-linked protein contactin ([@bib13]; [@bib24]; [@bib31]; [@bib36]), which binds to an isoform of neurofascin (NF155) present on the glial loops ([@bib38]; [@bib10]). Both Caspr and contactin are essential for the generation of the paranodal junction, and their absence results in the disappearance of the transverse bands, which are the hallmark of this axo-glial contact ([@bib6]; [@bib7]).

The generation and maintenance of neuronal polarity is achieved through specific sorting mechanisms that are followed by anchoring and clustering of various membrane proteins to distinct domains ([@bib46]). In myelinated fibers, the location of such domains is controlled by the ensheathing glial cell and by intrinsic determinants within the axon ([@bib14]; [@bib11]; [@bib20]; [@bib22]; [@bib44]; [@bib40]; [@bib5]; [@bib29]; [@bib34]). The localization of Caspr during the generation of the paranodal junction may be mediated by its interaction with both a glial ligand and cytoplasmic components within the axon ([@bib29]; [@bib36]; [@bib28]). The presence of Caspr at the paranodes and the juxtamesaxon ([@bib24]; [@bib2]), as well as its appearance in a spiral below the overlying turn of the paranodal loops that forms during development ([@bib28]), strongly suggests that its localization in the axon is regulated by the overlying myelin sheath. The extracellular region of Caspr binds laterally to contactin when both proteins are expressed in the same cell (i.e., cis interactions; [@bib31]), generating a receptor complex that binds neurofascin ([@bib41]; [@bib10]). The interaction with contactin is required for an efficient export of Caspr from the endoplasmic reticulum and its transport to the plasma membrane in transfected cells ([@bib15]). In agreement, in contactin-null mice, Caspr is retained within neuronal cell bodies, demonstrating that contactin is essential for axonal sorting of Caspr ([@bib7]). Furthermore, contactin is absent from the paranodal junction in mice lacking Caspr ([@bib6]), suggesting that the localization of both proteins at this site is interdependent. Similarly, disruption of the paranodal junction in galactolipid-deficient mice results in the disappearance of both proteins from the paranodes ([@bib12]; [@bib33]). The absence of contactin from the paranodal junction in mice lacking Caspr may suggest that the latter is required to anchor the Caspr--contactin complex to the axonal cytoskeleton at this site. A candidate protein that may connect Caspr to the axonal cytoskeleton at the paranodes is 4.1B, a member of the protein 4.1 family, which links membrane proteins with the actin/spectrin cytoskeleton ([@bib3]; [@bib24]; [@bib18]) and is found at the axonal paranodes and juxtaparanodal region ([@bib26]; [@bib33]).

In this study we used transgenic mice expressing a deletion mutant of Caspr lacking its cytoplasmic region to examine the mechanisms involved in the localization of the Caspr--contactin complex at the paranodal junction. Our results suggest that although the extracellular region of Caspr is sufficient to direct it to the paranodal junction, retention of the Caspr--contactin complex at this site requires the intracellular domain of Caspr, which may link it to the axonal cytoskeleton through protein 4.1B.

Results
=======

Generation of transgenic mice expressing a deletion mutant of Caspr in neurons
------------------------------------------------------------------------------

During myelination, Caspr is targeted to the paranodal junctions, located at both sides of the node of Ranvier. To determine whether the intracellular region of Caspr contains signals involved in its localization at the paranodal junctions, we have constructed a deletion mutant in which this domain was replaced with a hemagglutinin tag (CSPdCT--HA; [Fig. 1](#fig1){ref-type="fig"}). As a control, we have generated a tagged version of Caspr (CSP--HA) by fusing the HA tag at the carboxy terminus of the molecule. The presence of the HA tag in these constructs enables a clear distinction between the endogenous and the expressed proteins. The expression of these constructs in transfected HEK-293 cells could be detected using an HA tag antibody as well as an antibody directed against the extracellular domain (i.e., CSP--HA and CSPdCT--HA); an antibody against Caspr\'s intracellular region recognized CSP--HA but not CSPdCT--HA ([Fig. 1](#fig1){ref-type="fig"}). We next examined the ability of the tagged proteins to associate with contactin, as this interaction was previously shown to be required for surface expression and axonal transport of Caspr ([@bib15]; [@bib7]). As shown in [Fig. 1](#fig1){ref-type="fig"} C, when coexpressed in HEK-293 cells, both CSP--HA and CSPdCT--HA formed a stable complex with contactin, which could be immunoprecipitated by an HA tag antibody. Furthermore, both transgenes were efficiently expressed on the cell surface, as was evident by staining the cells with a monoclonal antibody that recognized the extracellular domain of Caspr in intact cells ([Fig. 1](#fig1){ref-type="fig"} D), as well as by surface biotinylation experiments (unpublished data).

![**Structure and expression of Caspr constructs.** (A) Schematic representation of the various Caspr constructs used in this study. In CSP--HA, an HA tag was added after the last amino acid of human Caspr, whereas in CSPdCT--HA, the HA tag replaced its cytoplasmic domain. Cyto, cytoplasmic region; Disc, discoidin-like domain; EGF, EGF repeat; fib, fibrinogen-like domain; LamG, laminin G domain; PGY, a proline/glycine/tyrosine-rich region; TM, transmembrane domain. (B) Expression of Caspr constructs in transfected cells. Sample of cell lysates prepared from parental HEK-293 (none), or cells transfected with CSP--HA (HA), CSPdCT--HA (dCT-HA), or human Caspr were used for immunoprecipitation and immunoblot analyses using anti-Caspr (top) or anti-HA antibody (bottom). Note that the anti-Caspr antibody used is directed against the cytoplasmic tail of the protein and therefore does not recognize CSPdCT--HA, which was detected by the HA antibody. Mol wt markers in kD are shown on the right. (C) Coimmunoprecipitation of contactin and Caspr mutants. HEK-293 cells were transfected with contactin alone (293), or together with CSP--HA (HA) or CSPdCT--HA (dCT) as indicated. Immunoprecipitation was performed with an antibody to HA tag (HA) or to contactin (Con) as indicated on the right of each panel (IP), followed by immunoblotting with anticontactin antibody. (D) Cell surface expression of Caspr constructs in transfected COS7 cells. Cells were transfected with contactin and CSP--HA or CSPdCT--HA as indicated on the top. Cells were fixed and stained with an antibody against the extracellular region (ECD) or an HA tag antibody found in the intracellular region of each Caspr construct (Cyto), with (+) or without (−) prior permeabilization (TX). The nuclei of the cells were labeled with DAPI (blue).](0203050f1){#fig1}

To direct the expression of these Caspr constructs in neurons, they were placed under the transcription regulatory elements of Thy1.2, a GPI-linked cell surface glycoprotein expressed in the CNS in peripheral long-projecting neurons, thymus, and fibroblasts ([@bib17]). The expression cassette used in the present study contained a deletion in the third intron of the Thy1.2 gene, restricting the expression of the transgenes to the nervous system ([@bib9]; [@bib16]). An important advantage of this system is that the expression of the transgene starts around postnatal day 6, allowing the investigation of relatively late events, such as myelination, without interfering with the early stages of nervous system development. All constructs were derived from the human Caspr gene in order to facilitate the detection of the transgene in the progenies. As depicted in [Fig. 2](#fig2){ref-type="fig"}, the expression of both transcripts and proteins of the two tagged molecules were detected in brains of the transgenic mice. When compared with the endogenous Caspr protein by immunobloting, the expression levels of the transgenes were lower and varied from 20 to 30% for CSPdCT--HA and CSP--HA, respectively. Similar levels of the transgenes were detected in several lines of transgenic mice that were generated for each construct (unpublished data). In the CNS, the transgenes had first been detected at postnatal day 5 and their level increased further as development proceeded until they reached their maximum levels in the adult ([Fig. 2](#fig2){ref-type="fig"} C; unpublished data). Thus, the expression of the transgenes occurs concomitantly with the time endogenous Caspr was first detected in the paranodes ([@bib35]). As observed in transfected cells ([Fig. 1](#fig1){ref-type="fig"} C), contactin could be coimmunoprecipitated using an anti-HA antibody from brain lysates prepared from the transgenic animals, but not from a wild-type mouse. These results demonstrate that both CSPdCT--HA and CSP--HA are associated with contactin in vivo as the endogenous Caspr protein ([Fig. 2](#fig2){ref-type="fig"} D).

![**Expression of Caspr mutants in transgenic mice.** (A) RT-PCR analyses. RNA was isolated from brains of adult transgenic animals expressing CSPdCT--HA (dCT--HA) or CSP--HA (HA) or control mice and used as a template for RT-PCR analysis using a primer set that recognizes CSP--HA and CSPdCT--HA. Plasmid templates containing the various mutants were used as specificity controls. (B) Protein expression of Caspr transgenes in adult mice brains. Brain membrane lysates from wild-type (WT) and the two Caspr transgenic mice were subjected to immunoprecipitation and immunoblotting using an antibody against Caspr or HA tag as indicated at the bottom of each panel. The immunoblots are shown along with mol wt markers in kD on the right. (C) Expression of Caspr and CSPdCT--HA during development. Brain membrane proteins were prepared from CSPdCT--HA mice at different postnatal days as indicated and subjected to immunoblot analyses with antibody to Caspr (top) or HA tag (bottom). (D) Interaction of Caspr transgenes with contactin in mouse brain. Brain lysates of wild-type (WT), CSP--HA (HA), or CSPdCT--HA (dCT) mice were subjected to immunoprecipitation with an antibody to HA tag (HA), Caspr, or contactin (Con) as indicated on the left of each panel. The resulted complexes were immunoblotted with an anticontactin antibody.](0203050f2){#fig2}

Localization of Caspr transgenes in myelinated fibers in the PNS and CNS
------------------------------------------------------------------------

We next examined the localization of the expressed proteins along the sciatic nerve. As depicted in [Fig. 3](#fig3){ref-type="fig"}, double labeling of teased fiber preparations using Na^+^ channels and HA tag antibodies revealed that both the full-length version of Caspr (CSP--HA) and the mutant lacking the cytoplasmic domain (CSPdCT--HA) were found in the paranodes. No staining was observed using an HA tag antibody in wild-type nerves. In addition, normal paranodal localization of the endogenous Caspr was observed in all the examined fibers from these transgenic animals. A similar pattern was also found in the CNS ([Fig. 4](#fig4){ref-type="fig"}). Staining of optic nerve sections from wild-type and transgenic mice with an antibody to Caspr revealed a normal intermittent staining surrounding the nodes of Ranvier. Paranodal labeling of the HA tag was observed in optic nerves derived from CSP--HA and CSPdCT--HA but not from wild-type control animals ([Fig. 4](#fig4){ref-type="fig"}, A--C). Double labeling for HA tag and Caspr showed that CSP--HA and CSPdCT--HA transgenes were found only in part of the axons. Such variation of transgene expression using the Thy1 promoter is well documented ([@bib9]) and results from stochastic expression of the transgene in a subset of retinal ganglion cells ([@bib16]). Altogether, these experiments demonstrated that the intracellular region of Caspr is not essential for proper targeting of the protein to the paranodal junction in myelinated axons.

![**Localization of Caspr transgenes in peripheral nerve.** Teased sciatic nerves from adult wild-type (WT) or the two transgenic mice (as indicated on top of the figure) were double labeled with an antibody against Na^+^ channel (red) and with either Caspr (green, top) or HA tag (green, bottom). Paranodal localization of the transgenes was detected in all the axons that expressed the transgenes. Bar, 10 μm.](0203050f3){#fig3}

![**Immunolocalization of Caspr transgenes in CNS white matter.** Sections of adult optic nerves from wild-type (A, D, and G), CSP--HA (B, E, and H), and CSPdCT--HA mice (C, F, and I) were double labeled with an antibody to Na^+^ channel (red) and HA tag (green; A--C), Na^+^ channel (red) and Caspr (green; D--F), or HA tag (red) and Caspr (green; G--I). Bar, 10 μm. Note that Caspr transgenes were not expressed in all retinal ganglion cells and thus were only found in 30--40% of the paranodes as detected by a Caspr antibody (D--F, yellow).](0203050f4){#fig4}

Retention of the Caspr--contactin complex at the paranodes requires the cytoplasmic tail of Caspr
-------------------------------------------------------------------------------------------------

To further determine whether the transgenes were properly located at the paranodal septate-like junctions at the ultrastructural level, we examined their localization in optic nerves using immunoelectron microscopy. In cross sections at the level of the paranodes of wild-type and CSPdCT--HA mice, staining with an antibody against the intracellular region of Caspr, which only recognizes the endogenous protein, resulted in a circumferential labeling surrounding the axon ([Fig. 5, A and B](#fig5){ref-type="fig"}). A similar staining pattern was obtained in optic nerves from CSP--HA mice labeled with an HA tag antibody ([Fig. 5](#fig5){ref-type="fig"} C). In contrast, specific labeling of optic nerves from CSPdCT--HA animals using an antibody to HA tag was frequently detected within the axon ([Fig. 5](#fig5){ref-type="fig"} D). At these sites, the gold particles were occasionally surrounded by a membrane configuration that was better detected by carefully tilting the sample. In favorable planes of the section, the staining was clearly observed within a vesicular structure ([Fig. 5](#fig5){ref-type="fig"} F, inset). We then repeated the same analysis using longitudinal sections of optic nerves from the different transgenic animals. As expected, the endogenous protein was clearly detected at the axonal membrane in optic nerve sections from wild-type mouse ([Fig. 5](#fig5){ref-type="fig"} E). Similar staining was also revealed using an HA tag antibody on optic nerve sections from CSP--HA (unpublished data). In contrast, in CSPdCT--HA mice, HA tag labeling was not confined to the axolemma, and was also located within the axon ([Fig. 5, F and G](#fig5){ref-type="fig"}). As summarized in [Table I](#tbl1){ref-type="table"}, internal distribution of the gold particles of HA-labeled nerves was found in 76.9% of the sections examined in CSPdCT--HA, compared with only 5.3% in CSP--HA. The latter was comparable to the 6.6% of internal labeling of Caspr detected in wild-type nerves. Importantly, staining of CSPdCT--HA at the axonal circumference was observed in 66% of the sections, demonstrating that this mutant was still residually found at the paranodal junction. The presence of CSPdCT--HA molecules within the axon may result from its reduced insertion into the axolemma, or alternatively from its destabilization and internalization due to the inability of this mutant to interact with cytoskeletal components at the paranodal junction.

![**Immunoelectron microscopy localization of Caspr transgenes and contactin in optic nerve.** Immunogold labeling of Caspr in cross sections at the paranodal level of optic nerves from adult wild type (A) or CSPdCT--HA (B). Similar sections were labeled with HA tag antibody in optic nerve from CSP--HA (C) or CSPdCT--HA (D) animals. Longitudinal sections at nodal regions of optic nerve from wild type labeled for Caspr (E) or from CSPdCT--HA mice labeled for HA tag (F and G). Note that in both cross and longitudinal sections, whereas the endogenous Caspr or HA tag in CSP--HA animals was confined to the inner surface of the axonal membrane in the paranodes, HA tag labeling in CSPdCT--HA mice was observed in the axonal cytoplasm at the paranodes. At a higher magnification, HA tag staining in optic nerves from CSPdCT--HA mice was clearly detected in vesicular structures (F, inset). Labeling of contactin in cross sections of optic nerve from wild-type (H), CSP--HA (I), or CSPdCT--HA mice (J--K). Bars, 0.2 μm (except for inset, which is 0.02 μm).](0203050f5){#fig5}

###### Quantitation of the distribution of Caspr transgenes at the paranodal region by immunoelectron microscopy

  Mouse/Ab        Internal        Circumference
  --------------- --------------- ---------------
  WT/Caspr        6.6% (3/45)     100% (45/45)
  CSP--HA/HA      5.3% (1/19)     100% (19/19)
  CSPdCT--HA/HA   76.9% (30/39)   66% (24/39)

Cross sections of optic nerves at the paranodal level from wild-type mice stained for Caspr, or CSP--HA and CSPdCT--HA stained with an antibody to HA tag (mouse/Ab) were analyzed. The presence of the gold particles within the axon (internal) or at the axolemma (circumference) was scored. Results are shown as a percentage of the sections examined along with the total numbers analyzed in parentheses. This quantitation demonstrates that although Caspr and CSP--HA are predominantly concentrated at the paranodal junction, CSPdCT--HA is found in both the paranodal junction and within the cytoplasm.

Because CSPdCT--HA was associated with contactin similarly to a wild-type Caspr ([Fig. 1](#fig1){ref-type="fig"} C and [Fig. 2](#fig2){ref-type="fig"} D), we examined whether the mislocalization of this mutant within the axon may also affect the subcellular localization of contactin. Whereas contactin was detected at the axonal circumference in optic nerve from wild-type and CSP--HA mice ([Fig. 5, H and I](#fig5){ref-type="fig"}), in optic nerves derived from CSPdCT--HA animals, it was less confined to the axonal circumference and was occasionally seen within the axon ([Fig. 5, J and K](#fig5){ref-type="fig"}). Altogether, these results suggest that although the extracellular region of Caspr is sufficient to direct it to the paranodes, its cytoplasmic domain is required for retention of the Caspr--contactin complex at the paranodal junction.

The cytoplasmic region of Caspr is required for binding and immobilization of protein 4.1B
------------------------------------------------------------------------------------------

Our results so far suggest that the maintenance of the Caspr--contactin complex at the paranodal junction may require its linkage to the axonal cytoskeleton through the cytoplasmic domain of Caspr. Such function may be provided by protein 4.1B that is concentrated at the axonal paranodal and juxtaparanodal regions ([@bib26]; [@bib33]). To explore this possibility, we performed pulldown and coimmunoprecipitation experiments to examine whether 4.1B interacts with Caspr. As depicted in [Fig. 6](#fig6){ref-type="fig"} A, glutathione-*S*-transferase (GST) fusion protein containing the cytoplasmic domain of Caspr, but not GST alone, pulled down protein 4.1B from HEK-293 cells expressing this protein. Protein 4.1B could also be coimmunoprecipitated using two different antibodies to Caspr from rat brain lysate ([Fig. 6](#fig6){ref-type="fig"} B). Furthermore, protein 4.1B was associated with CSP--HA but not CSPdCT--HA ([Fig. 6](#fig6){ref-type="fig"} C), demonstrating that the intracellular domain of Caspr mediates its association with protein 4.1B. We next examined whether clustering of the Caspr--contactin complex at the plasma membrane could affect the localization of protein 4.1B. To induce clustering of this complex, we used an Fc fusion protein containing the carbonic anhydrase domain of RPTPβ (βC--Fc), previously shown to bind contactin ([@bib30]). As shown in [Fig. 6](#fig6){ref-type="fig"} D, expression of CSPdCT--HA, contactin, and protein 4.1B at the plasma membrane was detected in HeLa cells coexpressing these proteins. As expected, binding of βC--Fc to these cells, without allowing clustering to occur, resulted in an identical pattern to that obtained using a contactin antibody ([Fig. 6](#fig6){ref-type="fig"} D, compare the second and fourth panels) or an antibody against Caspr (unpublished data). Clustering of βC--Fc fusion protein on cells expressing protein 4.1B, contactin, and either CSP--HA or CSPdCT--HA resulted in aggregation of contactin and the tagged Caspr molecules ([Fig. 6](#fig6){ref-type="fig"} E). In contrast, protein 4.1B was incorporated into these clusters when coexpressed with CSP--HA but not with CSPdCT--HA.

![**Interaction of Caspr with protein 4.1B.** (A) Pulldown of protein 4.1B by the cytoplasmic domain of Caspr. Lysates of HEK-293 cells expressing protein 4.1B were mixed with agarose-bound GST or GST fusion protein containing the cytoplasmic domain of Caspr as indicated. Bound proteins were immunoblotted with an antibody to protein 4.1B. Immunoprecipitation with an antibody to protein 4.1B (4.1B) was used as a control. (B) Coimmunoprecipitation of protein 4.1B with Caspr from rat brain. Adult rat brain lysates were subjected to immunoprecipitation with antibodies to protein 4.1B (4.1B) or the cytoplasmic (Caspr/CT) or extracellular (Caspr/ECD) domains of Caspr as indicated. Preimmune serum (CS) or protein A beads (beads) were used as controls. (C) Association of protein 4.1B with CSP--HA, but not with CSPdCT--HA. HEK-293 cells were transfected with CSP--HA or CSPdCT--HA, with (+m4.1B) or without myc-tagged protein 4.1B as indicated on the top. Cell lysates were subjected to immunoprecipitation with an antibody against the extracellular domain of Caspr. Washed immune complexes were separated on SDS gel and immunoblotted with an antibody to myc (right) or HA tag (left). The sizes of mol wt markers are shown on the right in kD. (D) Binding of βC--Fc fusion protein under nonclustering conditions. Hela cells expressing CSPdCT--HA, contactin, and protein 4.1B were stained with the indicated antibodies or with βC--Fc fusion protein. The second and fourth panels show the same cell stained for contactin and the βC--Fc fusion protein. (E) Clustering of CSP--HA, but not CSPdCT--HA, induces aggregation of protein 4.1B. Hela cells expressing contactin, protein 4.1B, and CSP--HA (HA) or CSPdCT--HA (dCT), as indicted on the bottom of each column, were allowed to bind βC--Fc followed by clustering with Cy3-conjugated anti--human Fc antibody. Cells were stained with an antibody to Caspr, contactin, or protein 4.1B as indicated in the upper row. The distribution of the clustered βC--Fc fusion protein and the merged images (βC--Fc, red; antibody staining, green) are shown in the middle and lower rows, respectively. Note that although βC-Fc induced clustering of contactin, CSP--HA, and CSPdCT-HA, immobilization of protein 4.1B into these clusters occurred in CSP--HA- but not in CSPdCT--HA-expressing cells.](0203050f6){#fig6}

To further analyze whether the interaction of Caspr with protein 4.1B affected the stabilization of Caspr on the cell surface, we constructed two chimeric proteins in which the transmembrane and cytoplasmic domain of Caspr (ConCT) or a deletion mutant lacking nine amino acids in its juxtamembrane region (ConJXCT) were fused to the extracellular domain of contactin ([Fig. 7](#fig7){ref-type="fig"} A). The latter was constructed based on the observation that the juxtamembrane region of Caspr contains a putative binding site for members of the protein 4.1 family ([@bib24]; [@bib31]; [@bib18]). These chimeras were efficiently expressed on the cell surface, thus resulting in the targeting of the cytoplasmic domain of Caspr to the plasma membrane ([Fig. 7](#fig7){ref-type="fig"} B). However, only ConCT, not ConJXCT, formed a complex with protein 4.1B ([Fig. 7](#fig7){ref-type="fig"} C), and induced its aggregation at the plasma membrane upon clustering with βC--Fc ([Fig. 7](#fig7){ref-type="fig"} D), demonstrating that ConJXCT lacks the binding site for protein 4.1B. Surface biotinylation experiments were then used to examine the internalization of ConCT or ConJXCT from the cell surface. HEK-293 cells expressing protein 4.1B and ConCT or ConJXCT were biotinylated with the reversible membrane-impermeable reagent sulfo-NHS-*S*-*S*-biotin and then transferred to 37°C in medium containing βC--Fc to allow internalization. The remaining biotinylated proteins on the cell surface were removed with glutathione, and internalized proteins were precipitated using immobilized avidin and analyzed by immunoblotting with an HA tag antibody. As depicted in [Fig. 7](#fig7){ref-type="fig"} E, during the first 20 min of incubation at 37°C, ∼10% of the labeled ConJXCT was internalized. In contrast, ConCT was not detected within the cell during this time, suggesting that the interaction with protein 4.1B stabilized the expression of this chimera on the cell surface.

![**Protein 4.1B binds a short sequence at the transmembrane domain of Caspr.** (A) Schematic representation of contactin--Caspr chimeras. ConCT contains the extracellular region of contactin fused to the transmembrane and cytoplasmic domain of Caspr. ConJXCT lacks nine amino acids from the juxtamembrane domain of Caspr (sequence shown in the bottom). Both chimeras contain an HA tag at their carboxy terminus. (B) Cell surface localization of the chimeras. HEK-293 cells expressing ConCT or ConJXCT, as indicated on the top, were labeled with biotin, lysed, and subjected to immunoprecipitation with an antibody to HA tag. Western blotting was performed with an antibody to HA (HA) or HRP-conjugated streptavidin to detect cell surface expression of the chimeras. (C) Association of ConCT, but not ConJXCT, with protein 4.1B. HEK-293 cells were transfected with ConCT or ConJXCT with (+m4.1B) or without a myc-tagged protein 4.1B, as indicated on the top. Cells expressing 4.1B alone (4.1B) served as an additional control. Immunoprecipitation (IP) and immunoblotting (blot) were performed with the different antibody combinations indicated on the left of each panel. The sizes of mol wt markers are shown on the right in kD. (D) Clustering of protein 4.1B by ConCT but not ConJXCT. HeLa cells expressing protein 4.1B and ConCT or ConJXCT were incubated with βC--Fc, with (+) or without (−) further clustering by anti--human Fc antibody as indicted on the left. Staining of the cells with an antibody to protein 4.1B (green) and βC--Fc (red) are shown along with the merged images on the right. Protein 4.1B was not incorporated into clusters in cells expressing ConJXCT. (E) Internalization of ConCT and ConJXCT from the cell surface during time in culture. HEK-293 cells expressing equal amounts of protein 4.1B and ConCT (top) or ConJXCT (bottom) were biotinylated using sulfo-NHS-*S*-*S*-biotin. Cells were then incubated with βC--Fc-containing medium at 37°C for the indicated times to allow internalization of biotinylated surface proteins. Cells were placed on ice to stop trafficking and, subsequently, were either treated with glutathione to remove remaining labeled proteins on the cell surface (internalized) or were left untreated (total). Biotinylated proteins were precipitated from cell lysates using agarose--streptavidin followed by immunoblotting with anti--HA tag antibody.](0203050f7){#fig7}

The ability of Caspr to mobilize protein 4.1B at the plasma membrane raises the possibility that Caspr may recruit 4.1B at the paranodal junction. Thus, to determine whether the paranodal localization of protein 4.1B depends on the presence of Caspr, we examined its distribution in myelinated nerves derived from contactin-deficient mice, which lack the Caspr--contactin complex at their paranodes ([@bib7]). Staining of teased sciatic nerves of 8-d-old wild-type mice revealed that protein 4.1B was concentrated at the paranodal junction ([Fig. 8](#fig8){ref-type="fig"}). In contrast, in age-matched nerves derived from contactin-null mice, protein 4.1 was distributed along the axon. It should be noted that in peripheral nerves at this age, Caspr is already localized at all paranodes, whereas Caspr2 is only starting to appear ([@bib33]). At older ages, paranodal accumulation of protein 4.1B was evident when Caspr2 was abnormally present at the paranodes instead of the juxtaparanodal region (unpublished data). Taken together, these results demonstrate that Caspr binds protein 4.1B through a short juxtamembrane sequence in its cytoplasmic tail, an association that could immobilize protein 4.1B to Caspr--contactin sites at the cell membrane. This in turn serves to stabilize Caspr at the cell surface.

![**Abnormal distribution of protein 4.1B in peripheral nerves of contactin-deficient mice.** Teased sciatic fibers from 8-d-old wild-type animals (WT) or mice lacking contactin (Con^−/−^) were double labeled with antibodies to Na^+^ channel (red) and protein 4.1B (green) as indicated in each panel. The merged images are shown in the right panels. Note that in contactin^−/−^ nerves, protein 4.1B is diffusely distributed along the axon.](0203050f8){#fig8}

Discussion
==========

The localization of ion channels and cell adhesion molecules to distinct domains at and around the nodes of Ranvier is thought to be regulated by signals provided by the overlying myelinating glial cells, as well as by cytoplasmic proteins within the axon ([@bib5]; [@bib29]). Caspr and contactin form an adhesion complex that is essential for the generation of the paranodal junction and, subsequently, for the organization of the nodal area ([@bib6]; [@bib7]). Here we report that although the extracellular region of Caspr was sufficient to direct it to the paranodal region, its cytoplasmic domain was necessary for retention of the Caspr--contactin complex at the junction. Ultrastructural analysis revealed that a Caspr mutant lacking its intracellular domain (CSPdCT--HA) was often found within the axon instead of the junctional axolemma. Notably, the CSPdCT--HA mutant was residually found at the paranodal junction, indicating that the intracellular region of Caspr is not required for its insertion into the plasma membrane. This conclusion was also supported by the observation that, similarly to the wild-type protein, this mutant efficiently reached the cell surface when coexpressed with contactin. Furthermore, deletion of a short juxtamembrane sequence that serves as a protein 4.1B binding site resulted in faster internalization of a chimeric protein in which the extracellular region of contactin was fused to the transmembrane and cytoplasmic domain of Caspr. Taken together, the presence of CSPdCT--HA within the axon most likely results from its instability at the paranodal junction and its internalization, rather than from its inability to be inserted into the axonal membrane. At present, it is not clear whether CSPdCT--HA is trafficked back to the cell body for degradation or is being recycled back to the plasma membrane.

Caspr and contactin form a lateral complex that is found at the paranodal junction ([@bib36]). Expression of the CSPdCT--HA mutant, but not of a full-length Caspr in transgenic mice, resulted in mislocalization of contactin. This result suggests that contactin, which is a GPI-linked protein anchored only to the outer leaflet of the membrane, depends on lateral association with Caspr to be maintained at specific sites along the axon. We propose that, after an initial targeting phase, which requires the extracellular domain of Caspr and depends on its interaction with contactin, a second process of stabilization takes place once the complex is deposited at the paranodes. This process is mediated by the intracellular domain of Caspr that links the complex to the axonal cytoskeleton ([Fig. 9](#fig9){ref-type="fig"}). This mechanism may well explain the notable lack of contactin from the paranodal domain in Caspr-null mice ([@bib6]); in the absence of Caspr, the linkage between contactin and the underlying axonal cytoskeleton at the paranodal junction is disrupted, resulting in the disappearance of contactin from this site.

![**Proposed mechanisms involved in the localization of Caspr and contactin at the paranodal junction.** Localization of Caspr at the paranodes involves several molecular interactions. During development of myelinated nerves, the interaction with contactin is required for a proper transport of Caspr out of the neuronal cell body. This complex is then accumulated at the paranodes probably as a result of its interactions with NF155 present on the glial loops. Once at the paranodal region, Caspr recruits protein 4.1B, which helps to stabilize the Caspr--contactin complex at the paranodal junction by linking it to the underlying axonal cytoskeleton.](0203050f9){#fig9}

The localization of cell adhesion molecules at cell junctions depends on their interaction with cytoskeleton-associated proteins ([@bib21]; [@bib25]). Candidate axonal proteins that may be involved in the localization of Caspr at the paranodal junction are members of the protein 4.1 family, which link membrane proteins with the actin/spectrin cytoskeleton ([@bib18]; [@bib4]). Four different 4.1 proteins are expressed in the nervous system at different subcellular locations ([@bib42]; [@bib48]; [@bib27]; [@bib47]); one of which (protein 4.1B) is concentrated at the axonal paranodes and juxtaparanodal region ([@bib26]; [@bib33]). A previous study showed that the cytoplasmic domain of Caspr could precipitate protein 4.1R from red blood cells and brain lysates ([@bib24]); however, a direct interaction between these two proteins was not demonstrated. Here, we extend these observations and show that Caspr physically associates with protein 4.1B. This association is mediated by a short juxtamembrane sequence (nine amino acids) present in the cytoplasmic domain of Caspr, which shows strong similarity to the protein 4.1R binding site found in erythrocyte glycophorin C ([@bib23]). Furthermore, we show that clustering of the Caspr--contactin complex on the cell surface immobilized protein 4.1B into these clusters, demonstrating that it is recruited to Caspr-containing sites on the plasma membrane. Consistent with this notion, we found that protein 4.1B was abnormally distributed along peripheral myelinated axons of contactin-null mice, which entirely lack the Caspr--contactin complex in their paranodes. Mislocalization of protein 4.1B was also observed in galactolipid-deficient mice, in which Caspr and contactin are displaced from the paranodes and are occasionally detected along the axon ([@bib33]). In these two paranodal mutants, the position of protein 4.1B was strongly correlated with the appearance of Caspr and Caspr2, suggesting that both Caspr family members may regulate its localization in myelinated axon. It was previously shown that neurexin-IV, a *Drosophila* homologue of Caspr and Caspr2, associates with and recruits the protein 4.1 homologue Coracle to the septate junction ([@bib3]). However, in contrast to the complete absence of Coracle from the septate junction in *neurexin IV* mutants, in *coracle* mutants, neurexin IV still reached the lateral membrane but was not subsequently confined at the septate junction ([@bib43]). These results indicate that although Coracle does not play a role in the targeting of neurexin IV to the plasma membrane, it is required for its maintenance at the junction. In analogy, we found that a deletion mutant of Caspr that lacks its intracellular domain and is unable to bind protein 4.1B was targeted to the paranodes, but was not maintained properly at the junction. Because of the geometry of the myelinating cell, the generation of the paranodal junction occurs gradually and continues as additional loops are attached to the axon ([@bib37]). As a result, paranodal accumulation of Caspr is composed of a number of rings that represent each turn of the myelin warp and, thus, does not constitute a uniform domain. During myelination of dorsal root ganglion neurons by Schwann cells in vitro, Caspr is detected in a spiral corresponding to the overlying turn of the forming paranodal loop, which is later consolidated into a tight helical coil ([@bib28]). We have found no evidence for the accumulation of 4.1B with Caspr during this process, suggesting that it may be recruited at a later stage when Caspr is already found at the paranodal junction. Taken together, it is reasonable to suggest that during the generation of the paranodal junction, protein 4.1B is immobilized at Caspr-containing sites on the axolemma. This in turn may bridge the Caspr--contactin complex to the rich cytoskeletal core present at the axonal paranodes ([@bib19]).

An important question is what determined the localization of Caspr and Caspr2 in myelinating axons. Our observation that a Caspr mutant lacking the cytoplasmic domain reaches the paranodal region argues against the possibility that the cytoplasmic domains of Caspr and Caspr2 are responsible for their differential targeting and localization. Instead, these are more likely to be controlled by specific interactions mediated by the distinct extracellular domains of Caspr and Caspr2 ([@bib32]). Although Caspr binds to contactin and indirectly to neurofascin 155 ([@bib10]; unpublished data), found at the paranodal junction, Caspr2 does not interact with these molecules, but may bind to TAG-1, a contactin family member found at the juxtaparanodes ([@bib39]). While uncovering a role for the cytoplasmic domain of Caspr in maintenance of the Caspr--contactin complex at the paranodes, our results do not exclude the possibility of an additional contribution of a glial ligand that binds the Caspr--contactin complex in this process. Nevertheless, our results raise the intriguing possibility that the chief function of Caspr is to provide a "transmembrane scaffold" that stabilizes the Caspr--contactin adhesion complex at the paranodal junction by connecting it to cytoskeletal components within the axon. This illustrates one mechanism by which the axonal cytoskeleton cooperates with glial cues to organize functional domains along myelinated axons.

Materials and methods
=====================

Constructs and transgenic mice
------------------------------

HA-tagged constructs were all generated from human Caspr cDNA using PCR and standard cloning procedures. In CSP--HA, the HA tag (amino acids YPYDVPDYAS) was inserted at position 1385 after the carboxy-terminal glutamic acid (E1384), whereas in CSPdCT--HA, it replaced the cytoplasmic sequence from the lysine at position 1312. These genes were cloned into a Thy1.2 expression cassette ([@bib9]), linearized, and introduced by pronuclear injection into fertilized eggs derived from CB6F1 mice. Pseudopregnant CD-1 outbreed albino females were used as foster mothers for embryo transfer. Founder mice were genotyped by Southern blot hybridization with a DNA fragment containing the first 730 bp of human Caspr. Founders were further crossed with CB6F1 mice and interbred to generate lines. Transgenic mice were routinely identified by PCR of tail genomic DNA, using the appropriate primers derived from human Caspr cDNA and the HA tag. The same primers were also used for RT-PCR analyses on RNAs prepared from mice brains. Myc tag protein 4.1B was generated by cloning the open reading of KIAA0987 downstream of a myc tag--containing pCDNA3 vector (Invitrogen). For the generation of ConCT and ConJXCT, the transmembrane and cytoplasmic domain of Caspr or a deletion mutant lacking nine amino acids in the juxtamembrane region ([Fig. 7](#fig7){ref-type="fig"}) were generated by PCR and attached after amino acid 1020 of human contactin ([@bib30]), replacing its GPI-linkage sequence.

Immunoprecipitation and immunoblot analysis
-------------------------------------------

For preparation of mouse brain membranes, adult brains were homogenized in a glass homogenizer in a buffer containing 20 mM Hepes, pH 7.4, 0.32 M sucrose, 1 mM EGTA, 1.5 mM MgSO~4~, 10 μg/ml aprotinin and leupeptin, and 1 mM PMSF. Nuclei and heavy cell debris were removed by low speed centrifugation (3,000 *g* for 10 min at 4°C), and the supernatants were centrifuged at 40,000 *g* for 60 min. Membrane pellets were solubilized in Triton X-100 lysis buffer ([@bib32]) for 1 h on ice and then the detergent-insoluble material was removed by centrifugation. Coimmunoprecipitation of Caspr and 4.1B was done using 14-wk-old rat brain homogenized in Triton X-100 lysis buffer ([@bib32]). For immunoprecipitation, solubilized membrane supernatants were incubated with antibodies coupled to Sepharose--protein A beads (Amersham Pharmacia Biotech) or to agarose anti--mouse IgG beads (Sigma-Aldrich), followed by Western blotting analyses using the ECL detection system (Amersham Pharmacia Biotech) as previously described ([@bib32]). The antibodies used, polyclonal antibody P6061 directed to the intracellular region of Caspr and monoclonal antibody M275 directed to its extracellular domain, were previously described ([@bib31]; [@bib32]). Monoclonal antibody for Na^+^ channels was previously described ([@bib35]). Antibodies against HA tag and myc tag were purchased from Boehringer and Santa Cruz Biotechnology, Inc. Polyclonal antibodies against contactin were generated by immunization of rabbits with a purified human contactin--Ig fusion protein as described previously ([@bib36]). Polyclonal antibodies against protein 4.1B were generated by immunizing rabbits with a GST fusion protein containing amino acids 7-P778-L968 of human protein 4.1B (GenBank/EMBL/DDBJ accession no. [AB023204](AB023204)) according to Yamakawa et al., 2000. Removal of antibodies against GST and affinity purification of the antibodies were performed as described previously ([@bib32]).

Internalization assay
---------------------

The internalization of ConCT and ConJXCT was analyzed by cell surface biotinylation as previously described ([@bib8]). HEK-293 cells stably expressing protein 4.1B were transfected with ConCT or ConJXCT. 48 h later, the cells were biotinylated with 0.5 mg/ml sulfo-NHS-*S*-*S*-biotin in PBS for 30 min at 4°C. Excess biotin was removed by three washes with TBS and the cells were then incubated in 37°C with DME containing βC--FC for various times to allow for endocytosis. Biotin attached to proteins still remaining on the cell surface was stripped by washing the cells twice with 50 mM glutathione in a buffer containing 75 mM NaCl, 75 mM NaOH, and 10% FCS on ice. For each time point, a sample of cells not treated with glutathione was used as a control. The cells were then incubated twice for 15 min in buffer containing 50 mM iodoacetamide, 1% BSA in PBS and further lysed with 1% Triton X-100 solubilization buffer ([@bib32]). Biotinylated proteins were isolated from the supernatant using UltraLink immobilized NeutrAvidin beads (Pierce Chemical Co.). Beads were washed three times with HNTG buffer ([@bib32]), eluted with DTT-containing SDS-PAGE buffer, and subjected to Western blotting using an anti--HA tag antibody.

Immunofluorescence
------------------

### Tissues.

Mouse optic nerves were isolated and directly frozen in O.C.T. mounting medium (Tissue-Tek) and 10-μm sections were cut with a cryostat. For sciatic nerve labeling experiments, nerves were isolated and fixed for 10 min in Zamboni\'s fixative, washed in PBS, and teased into single fibers on gelatin-coated slides. Both optic and sciatic nerve preparations were then permeabilized for 20 min in cold methanol at −20°C. Slides were then washed with PBS, blocked for 30 min in PBS containing 10% goat serum, 1% glycine, and 0.1% Triton X-100 (PBTGG), and incubated with first antibodies at the appropriate concentrations. After subsequent washes in PBS, the slides were reacted with Cy3- or Alexa^®^488-coupled secondary antibodies obtained from Jackson ImmunoResearch Laboratories or Molecular Probes and further processed as described previously ([@bib32]). Immunofluorescence slides were viewed and analyzed using a Deltavision wide-field deconvolution microscope (Applied Precision), a Bio-Rad Laboratories confocal microscope, or a ZEISS Axioplan microscope equipped with a SPOT-II (Diagnostic Instruments) cooled CCD camera.

### Cells.

Cells seeded on glass slides were transfected using Lipofectamine plus reagent (GIBCO BRL). 48 h later, cells were washed with PBS and fixed in 4% paraformaldehyde for 15 min at room temperature. After washing with PBS, the cells were incubated in blocking buffer either with (PBTGG) or without 0.1% Triton X-100 (PBGG) for 30 min at ambient temperature. Primary antibodies were diluted in either PBTGG or PBGG and incubated for 2 h. After three washes with PBS, slides were incubated with secondary antibodies for 45 min in DAPI-containing PBGG, subsequently washed with PBS, mounted in elvanol, and analyzed as above. For clustering experiments, cells were treated with DME containing 0.5--1 μg/ml βC--Fc for 30 min at 4°C followed by three washes with cold DME on ice. Cells were further incubated with Cy3-conjugated anti--human Fc (Jackson ImmunoResearch Laboratories) in DME containing 2% low IgG FCS (GIBCO BRL), 20 mM Hepes for 15 min at room temperature and then 15 min at 37°C. Unbound antibody was removed by three washes with PBS and the cells were fixed with 4% paraformaldehyde. Nonclustered samples were fixed as above before the incubation with the Cy3-conjugated anti--human Fc.

EM
--

Optic nerve tissues were fixed for 30 min in 4% paraformaldehyde, 0.1% glutaraldehyde, 0.2% picric acid, and 5 mM CaCl~2~ in 0.1 M buffer cacodylate, pH 7.4. The tissue was then cut in to 1-mm segments. The samples were further incubated in the same fixative for 2 h at 24°C and 10 h at 4°C. After extensive washing with cacodylate buffer, the samples were cryoprotected by immersion for 5 min in 15% sucrose and 5% glycerol and 30 min in 30% sucrose and 10% glycerol and then frozen and thawed twice in isopentane cooled in liquid nitrogen. Tissues were embedded in 7% agar noble and cut at 50-μm thickness using a vibrotome. Sections were blocked for 1 h in 0.01% saponin (Sigma-Aldrich), 3% normal goat serum, 0.5% BSA, and 0.1% glycine in PBS. First antibodies were incubated overnight in PBS containing 1% normal goat serum, 0.1% glycine, and 0.5% BSA, extensively washed in PBS, and incubated with Nanogold 1:40 secondary antibodies (Nanoprobe). The sections were then washed and fixed for 30 min as above and rinsed in distilled water before silver intensification using HQ Silver (Nanoprobe). Samples were fixed in 3% glutaraldehyde, 3% paraformaldehyde, and 0.2% picric acid in cacodylate buffer and then with 1% osmium tetraoxide, 0.5% potassium dichromate, and 0.5% potassium hexacyanoferrate. The tissue was postfixed with 2% aqueous uranyl acetate followed by ethanol dehydration and embedded in EMBED 812 (EMS). Sections were cut using a diamond knife (Diatome) and examined using a Philips CM-12 transmission electron microscope at accelerating voltage of 100 kV.
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